Sharp rise in opioid abuse may benefit drug delivery contenders

Opioid addiction therapy is one of the most active areas of drug delivery trials and technology. The contenders to develop new methods of tackling the problem should receive a boost from a new study by the federal Agency for Healthcare Research & Quality, which found that the overuse of pain medications has resulted in a 5% average annual increase in adult hospital stays between 1993 and 2012, culminating in a 153% increase over the course of the study. The issue stems mostly from prescription medications such as morphine, codeine or oxycodone, among others. Over 12 million people used opioids nonmedically in 2010, and about 17,000 deaths were linked to opioid abuse in the same year. Study

Suggested Articles

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a…

Counting on a novel nasal-spray device to set it apart from its rivals, drug delivery specialist OptiNose is preparing to file its new chronic rhinosinusitis…